Evaluation of Oncoxin-Viusid® in Prostate Cancer

Clinical trial NCT03543670 · COMPLETED

Trial details

NCT number: NCT03543670
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2017-09-16
Primary completion: 2018-04-12
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.